Stopping GLP-1 medications is linked to a higher risk of heart attack, stroke, and death. Recent research found that even ...

What if a medicine you thought of as “old news” suddenly showed up in new research with fresh benefits that might stretch well beyond its original purpose? That’s exactly the twist happening with a ...

Add Yahoo as a preferred source to see more of our stories on Google. A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast ...

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems.

This news might break your heart — literally. A shocking new study found that the go-to treatment doctors have been using to manage heart attacks for the last 40 years may offer no real benefit for ...

This study, published in BMJ Medicine, investigated what happens when people with Type 2 diabetes stop or interrupt their treatment with GLP-1 drugs.

A study finds heart benefits of GLP-1 drugs may fade after stopping treatment, while generics could soon lower costs in some countries.

When the heart struggles to pump efficiently, a cascade of events unfolds. Fluid accumulates in the lungs and extremities. Breathing becomes labored. Simple activities like climbing stairs or carrying ...

Cardiovascular disease is the second leading cause of death among cancer survivors, second only to cancer itself. The same treatments that can save patients from cancer may also r ...

A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...